Dashboard
Manage Tickers

GLSI


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

greenwich-lifesciences-expands-phase-iii-flamingo-01-breast-cancer-trial-to-austria-following-regulatory-approval
Greenwich LifeSciences Expands Phase III F...
10/09/2025 10:10:40

greenwich-lifesciences-strengthens-european-presence-as-flamingo-01-clinical-trial-adds-belgium-to-nine-approved-countries
Greenwich LifeSciences Strengthens Europea...
10/02/2025 10:08:06

The Company's application to European regulators has been formally approved, adding Belgium as an approved country in FLAMI...

greenwich-lifesciences-takes-fight-against-breast-cancer-recurrence-global-with-trial-expansion-into-portugal
Greenwich LifeSciences Takes Fight Against...
09/30/2025 10:12:21

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

greenwich-lifesciences-expands-phase-iii-flamingo-01-breast-cancer-immunotherapy-trial-to-ireland
Greenwich LifeSciences Expands Phase III F...
09/18/2025 10:11:14

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 12:11:03

the-fda-has-granted-fast-track-designation-to-greenwich-lifesciences-glsi-100-in-hla-a02-patient-population
The FDA Has Granted Fast Track Designation...
09/10/2025 10:03:51

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

greenwich-lifesciences-cuts-costs-by-bringing-breast-cancer-trial-management-in-house
Greenwich LifeSciences Cuts Costs by Bring...
08/19/2025 10:04:06

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

greenwich-lifesciences-expands-phase-iii-breast-cancer-trial-into-romania-after-regulatory-green-light
Greenwich LifeSciences Expands Phase III B...
08/13/2025 10:07:32

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

greenwich-lifesciences-q1-eps-025-down-from-019-yoy
Greenwich LifeSciences Q1 EPS $(0.25) Down...
05/20/2025 21:58:33

Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.25) per share. This is a 31.58 percent decrease over loss...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 12:05:58

hc-wainwright--co-maintains-buy-on-greenwich-lifesciences-raises-price-target-to-39
HC Wainwright & Co. Maintains Buy on Green...
04/21/2025 12:57:41

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price targe...

greenwich-lifesciences-provides-update-on-its-phase-iii-clinical-trial-flamingo-01-which-is-evaluating-glsi-100-an-immunotherapy-to-prevent-breast-cancer-recurrences
Greenwich Lifesciences Provides Update On ...
04/03/2025 12:04:05

Flamingo-01 Progress to Date & Future PlansThe Company recently confirmed that the preliminary HLA prevalence, safety, and ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/02/2025 12:05:45

greenwich-lifesciences-announces-immune-response-data-from-flamingo-01-phase-3-clinical-trial
Greenwich Lifesciences Announces Immune Re...
04/02/2025 10:02:40

FLAMINGO-01 Immune Response Data SummaryThe Company has analyzed the preliminary immune response data from FLAMINGO-01. Immune ...

greenwich-lifesciences-board-extends-lock-up-of-shares-owned-by-directors-officers-and-existing-pre-ipo-investors-to-march-31-2026
Greenwich LifeSciences Board Extends Lock-...
03/27/2025 10:04:15

greenwich-lifesciences-announced-an-update-on-flamingo-01-open-label-safety-data
Greenwich LifeSciences Announced An Update...
03/17/2025 10:47:32

FLAMINGO-01 Data Safety Monitoring Board (DSMB)The FLAMINGO-01 DSMB met twice in 2024, most recently in December 2024, and reco...

hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-38-price-target
HC Wainwright & Co. Reiterates Buy on Gree...
02/11/2025 17:36:23

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $38 price t...

greenwich-lifesciences-announced-the-following-update-on-flamingo-01-open-label-hla-data
Greenwich Lifesciences Announced The Follo...
02/10/2025 11:04:35

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blin...

greenwich-lifesciences-said-that-application-to-add-an-additional-11-sites-to-flamingo-01-in-spain-germany-and-poland-has-been-formally-approved-by-ema
Greenwich LifeSciences Said That Applicati...
01/29/2025 11:22:47

greenwich-lifesciences-has-activated-clinical-sites-in-poland-for-its-phase-3-trial-flamingo-01-which-is-evaluating-glsi-100-an-immunotherapy-to-prevent-breast-cancer-recurrences
Greenwich LifeSciences Has Activated Clini...
01/27/2025 11:02:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION